Cargando...
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
OBJECTIVE: In an ongoing, open-label, phase 1b study on the intrathecal administration of rituximab for progressive multiple sclerosis, an intraventricular catheter was inserted for drug delivery. The objective of this study was to characterize the limited white matter axonal injury evoked by cathet...
Guardado en:
| Publicado en: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Lippincott Williams & Wilkins
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972001/ https://ncbi.nlm.nih.gov/pubmed/27536708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000271 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|